| Income Statement |
| Total Revenue | 845.98M |
|
| Revenues (USD) | 845.98M |
| Cost of Revenue | 664.80M |
| Gross Profit | 181.18M |
| Operating Expenses | 108.73M |
| Research and Development Expense | 7.81M |
| Selling, General and Administrative Expense | 93.74M |
| Operating Income | 72.45M |
| Interest Expense | 10.60M |
| Income Tax Expense | 8.54M |
| Net Income | 49.99M |
| Net Income Common Stock | 49.99M |
| Net Income Common Stock (USD) | 49.99M |
| Consolidated Income | 49.99M |
| Earnings per Basic Share | 0.48 |
| Earnings per Basic Share (USD) | 0.48 |
| Earnings per Diluted Share | 0.47 |
| Earning Before Interest & Taxes (EBIT) | 69.13M |
| Earning Before Interest & Taxes (USD) | 69.13M |
| Weighted Average Shares | 103.40M |
| Balance Sheet |
| Cash and Equivalents | 410.05M |
| Cash and Equivalents (USD) | 410.05M |
| Trade and Non-Trade Receivables | 618.08M |
| Current Assets | 1.91B |
| Property, Plant & Equipment Net | 1.17B |
| Total Assets | 3.98B |
| Debt Current | 3.85M |
| Total Debt | 1.02B |
| Current Liabilities | 1.02B |
| Debt Non-Current | 1.02B |
| Total Liabilities | 2.14B |
| Accumulated Retained Earnings (Deficit) | 1.07B |
| Accumulated Other Comprehensive Income | -29.87M |
| Shareholders Equity | 1.84B |
| Shareholders Equity (USD) | 1.84B |
| Assets Non-Current | 2.07B |
| Total Debt (USD) | 1.02B |
| Deferred Revenue | 174.53M |
| Goodwill and Intangible Assets | 815.83M |
| Inventory | 280.21M |
| Liabilities Non-Current | 1.13B |
| Trade and Non-Trade Payables | 607.90M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 29.29M |
| Net Cash Flow from Financing | -6.20M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -91.18M |
| Capital Expenditure | -106.80M |
| Issuance (Repayment) of Debt Securities | -922.00K |
| Net Cash Flow from Investing | -106.80M |
| Net Cash Flow from Operations | 21.74M |
| Effect of Exchange Rate Changes on Cash | 74.00K |
| Share Based Compensation | 24.36M |